| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |